Poziotinib for uncommon ERBB mutations

Poziotinib for uncommon ERBB mutationsPoziotinib for uncommon <i>ERBB</i> mutations, Published online: 09 May 2018; doi:10.1038/s41571-018-0038-7Poziotinib for uncommon ERBB mutations

https://www.nature.com/articles/s41571-018-0038-7

Source: Nature Clinical Practice Oncology - May 9, 2018 Category: Cancer & Oncology Authors: Diana Romero Source Type: research

More News: Cancer & Oncology